Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luis E. Lara-Gonzalez"'
Autor:
Jovana R. Gotovac, Tanjina Kader, Julia V. Milne, Kenji M. Fujihara, Luis E. Lara-Gonzalez, Kylie L. Gorringe, Sangeetha N. Kalimuthu, Madawa W. Jayawardana, Cuong P. Duong, Wayne A. Phillips, Nicholas J. Clemons
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 2, Pp 689-713 (2021)
Background & Aims: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease pr
Externí odkaz:
https://doaj.org/article/a7e5902c1bfa452b8729ab028422f939
Autor:
Ran Li, Sneha Sant, Emmaline Brown, Franco Caramia, Bronte Nikolic, Kylie Clarke, Ann Byrne, Luis E Lara Gonzalez, Peter Savas, Stephen J Luen, Zhi Ling Teo, Balaji Virassamy, Paul J Neeson, Phillip K Darcy, Sherene Loi
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background PD-1 and PD-L1 inhibitors have poor efficacy in patients with trastuzumab-resistant advanced HER2-positive breast cancer. Tucatinib is a potent, selective anti-HER2 tyrosine kinase inhibitor with proven clinical benefit in the advanced set
Autor:
Madawa W. Jayawardana, Jovana R. Gotovac, Luis E. Lara-Gonzalez, Tanjina Kader, Wayne A. Phillips, Kylie L. Gorringe, Cuong Duong, Sangeetha N Kalimuthu, Kenji M Fujihara, Julia V. Milne, Nicholas J Clemons
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 2, Pp 689-713 (2021)
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 2, Pp 689-713 (2021)
Background & Aims Esophageal adenocarcinoma (EAC) develops from its precursor Barrett’s esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease pro